VERSED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Versed, and when can generic versions of Versed launch?
Versed is a drug marketed by HLR and Roche and is included in two NDAs.
The generic ingredient in VERSED is midazolam hydrochloride. There are nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the midazolam hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Versed
A generic version of VERSED was approved as midazolam hydrochloride by FRESENIUS KABI USA on June 20th, 2000.
Summary for VERSED
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 47 |
Clinical Trials: | 107 |
Patent Applications: | 4,768 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VERSED at DailyMed |
Recent Clinical Trials for VERSED
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Lawson Health Research Institute | Phase 3 |
University of Texas Southwestern Medical Center | Phase 3 |
National Institute of Mental Health (NIMH) | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for VERSED
US Patents and Regulatory Information for VERSED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hlr | VERSED | midazolam hydrochloride | INJECTABLE;INJECTION | 018654-002 | May 26, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hlr | VERSED | midazolam hydrochloride | INJECTABLE;INJECTION | 018654-001 | Dec 20, 1985 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | VERSED | midazolam hydrochloride | SYRUP;ORAL | 020942-001 | Oct 15, 1998 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VERSED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hlr | VERSED | midazolam hydrochloride | INJECTABLE;INJECTION | 018654-002 | May 26, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Hlr | VERSED | midazolam hydrochloride | INJECTABLE;INJECTION | 018654-001 | Dec 20, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Roche | VERSED | midazolam hydrochloride | SYRUP;ORAL | 020942-001 | Oct 15, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VERSED
See the table below for patents covering VERSED around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Africa | 7505418 | ⤷ Try a Trial | |
Canada | 1076572 | DERIVES DE LA DIAZEPINE (DIAZEPINE DERIVATIVES) | ⤷ Try a Trial |
Portugal | 64882 | DERIVES DE DIAZEPINE | ⤷ Try a Trial |
Yugoslavia | 40267 | ⤷ Try a Trial | |
Norway | 802651 | ⤷ Try a Trial | |
Sweden | 445918 | DIAZEPINDERIVAT TILL ANVENDNING SOM MELLANPRODUKTER | ⤷ Try a Trial |
Norway | 149136 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |